BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 29875192)

  • 21. Positive result of the Aspergillus galactomannan antigen assay using bronchoalveolar lavage fluid from a patient with an invasive infection due to Lichtheimia ramosa.
    Borrás R; Roselló P; Chilet M; Bravo D; de Lomas JG; Navarro D
    J Clin Microbiol; 2010 Aug; 48(8):3035-6. PubMed ID: 20554823
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
    Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
    Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of the Mucorales qPCR on blood to screen high-risk hematology patients is associated with better survival.
    Bellanger AP; Gbaguidi-Haore H; Berceanu A; Gouzien L; El Machhour C; Bichard D; Lanternier F; Scherer E; Millon L;
    Med Mycol; 2024 Mar; 62(4):. PubMed ID: 38533663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood Mucorales PCR to track down
    Aerts R; Bevers S; Beuselinck K; Schauwvlieghe A; Lagrou K; Maertens J
    Front Cell Infect Microbiol; 2022; 12():1080921. PubMed ID: 36569194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies.
    Nosari A; Anghilieri M; Carrafiello G; Guffanti C; Marbello L; Montillo M; Muti G; Ribera S; Vanzulli A; Nichelatti M; Morra E
    Haematologica; 2003 Dec; 88(12):1405-9. PubMed ID: 14687995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis of invasive aspergillosis and mucormycosis in immunocompromised patients by seminested PCR assay of tissue samples.
    Rickerts V; Just-Nübling G; Konrad F; Kern J; Lambrecht E; Böhme A; Jacobi V; Bialek R
    Eur J Clin Microbiol Infect Dis; 2006 Jan; 25(1):8-13. PubMed ID: 16416267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient.
    Hofman V; Dhouibi A; Butori C; Padovani B; Gari-Toussaint M; Garcia-Hermoso D; Baumann M; Vénissac N; Cathomas G; Hofman P
    Diagn Pathol; 2010 Jan; 5():1. PubMed ID: 20205795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interlaboratory evaluation of Mucorales PCR assays for testing serum specimens: A study by the fungal PCR Initiative and the Modimucor study group.
    Rocchi S; Scherer E; Mengoli C; Alanio A; Botterel F; Bougnoux ME; Bretagne S; Cogliati M; Cornu M; Dalle F; Damiani C; Denis J; Fuchs S; Gits-Muselli M; Hagen F; Halliday C; Hare R; Iriart X; Klaassen C; Lackner M; Lengerova M; Letscher-Bru V; Morio F; Nourrisson C; Posch W; Sendid B; Springer J; Willinger B; White PL; Barnes RA; Cruciani M; Donnelly JP; Loeffler J; Millon L
    Med Mycol; 2021 Feb; 59(2):126-138. PubMed ID: 32534456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular methods to improve diagnosis and identification of mucormycosis.
    Hammond SP; Bialek R; Milner DA; Petschnigg EM; Baden LR; Marty FM
    J Clin Microbiol; 2011 Jun; 49(6):2151-3. PubMed ID: 21508149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of BAL in the diagnosis of pulmonary mucormycosis.
    Glazer M; Nusair S; Breuer R; Lafair J; Sherman Y; Berkman N
    Chest; 2000 Jan; 117(1):279-82. PubMed ID: 10631232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of real-time polymerase chain reaction assay on blood for invasive aspergillosis and mucormycosis.
    Seo H; Kim JY; Son HJ; Jung J; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Kim SH
    Mycoses; 2021 Dec; 64(12):1554-1562. PubMed ID: 34013523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of in-house and commercial PCR assay in diagnosis of Covid-19 associated mucormycoss in an emergency setting in a tertiary care center.
    Pandey M; Sachdev J; Yadav RK; Sharad N; Kanodia A; Biswas J; Janani RS; Gupta S; Singh G; Ekka M; Rana B; Gourav S; Thakar A; Biswas A; Sikka K; Mathur P; Pushker N; Jyotsna VP; Kumar R; Soneja M; Wig N; Srivastava MVP; Xess I
    J Med Microbiol; 2023 Aug; 72(8):. PubMed ID: 37624041
    [No Abstract]   [Full Text] [Related]  

  • 35. Diagnosis of mucormycosis using an intercalating dye-based quantitative PCR.
    Bigot J; Godmer A; Prudenté L; Angebault C; Brissot E; Bige N; Voiriot G; Leger PL; Petit-Hoang C; Atallah S; Gouache E; Senghor Y; Valot S; Hennequin C; Guitard J
    Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35188208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aspergillus-PCR in bronchoalveolar lavage for detection of invasive pulmonary aspergillosis in immunocompromised patients.
    Buess M; Cathomas G; Halter J; Junker L; Grendelmeier P; Tamm M; Stolz D
    BMC Infect Dis; 2012 Oct; 12():237. PubMed ID: 23031334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis).
    Walsh TJ; Gamaletsou MN; McGinnis MR; Hayden RT; Kontoyiannis DP
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S55-60. PubMed ID: 22247446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction.
    Gu Z; Buelow DR; Petraitiene R; Petraitis V; Walsh TJ; Hayden RT
    Arch Pathol Lab Med; 2014 Nov; 138(11):1474-80. PubMed ID: 25357108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular identification of Mucorales in human tissues: contribution of PCR electrospray-ionization mass spectrometry.
    Alanio A; Garcia-Hermoso D; Mercier-Delarue S; Lanternier F; Gits-Muselli M; Menotti J; Denis B; Bergeron A; Legrand M; Lortholary O; Bretagne S;
    Clin Microbiol Infect; 2015 Jun; 21(6):594.e1-5. PubMed ID: 25726039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early diagnosis of invasive mould infections and disease.
    Lamoth F; Calandra T
    J Antimicrob Chemother; 2017 Mar; 72(suppl_1):i19-i28. PubMed ID: 28355464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.